WAQAS REHMAN NPI 1750546610

NPI Details

Waqas Rehman is a hematology and oncology internal medicine in Flemington, NJ with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Waqas Rehman NPI is 1750546610. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NORTHEASTERN OHIO UNIVERSITY COLLEGE OF MEDICINE
Graduation Year:2007

The provider's business location address is:

2100 WESCOTT DR
FLEMINGTON, NJ
ZIP 08822-603
Phone: (908) 788-6461
Fax: (908) 788-6412

The NPI 1750546610 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, aprepitant, 1 mg (HCPCS:J0185)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Injection, granisetron, extended-release, 0.1 mg (HCPCS:J1627)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Magnesium level (HCPCS:83735)
• Phosphate level (HCPCS:84100)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Unclassified drugs (HCPCS:J3490)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Drawing of blood for a medical problem (HCPCS:99195)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Blood creatinine level (HCPCS:82565)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Vitamin d-3 level (HCPCS:82306)
• Initial hospital observation care per day, typically 50 minutes (HCPCS:99219)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Calcium level, total (HCPCS:82310)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)

The enumeration date for this NPI number is 7/21/2008 and was last updated on 12/5/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: